References
- Katragadda S, Arora RR. Role of angiotensin-converting enzyme inhibitors in vascular modulation: beyond the hypertensive effects. Am J Ther 2010; 17(1):e11–e23.
- Hughes AD, Stanton AV, Jabbar AS, Chapman N, Martinez-Perez ME, McG Thom SA. Effect of antihypertensive treatment on retinal microvascular changes in hypertension. J Hypertens 2008; 26(8):1703–1707.
- Wang XZ, Jiang JY, Lu JF, . Different types of endothelial dysfunction and drug remediation of the SHR hypertensive process. Chin Pharmacol Bull. 2010; 26(2):163–168.
- Hong F, Ming L, Yi S, Zhanxia L, Yongquan W, Chi L. The antihypertensive effect of peptides: a novel alternative to drugs? Peptides 2008; 29(6):1062–1071.
- Murray BA, FitzGerald RJ. Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production. Curr Pharm Des 2007; 13(8):773–791.
- Nai-Yuan L, Juei-Tang C, Toshiki E, Ichiro N. The antihypertensive activity of angiotensin-converting enzyme inhibitory peptide containing in bovine lactoferrin. Chin J Physiol 2006; 49(2):67–73.
- Chironi G, Gariepy J, Denarie N, . Influence of hypertension on early carotid artery remodeling. Arterioscler Thromb Vasc Biol 2003; 23(8):1460–1464.
- Safar ME, Rizzoni D, Blacher J, Muiesan ML, Agabiti-Rosei E. Macro and micro vasculature in hypertension: therapeutic aspects. J Hum Hypertens 2008; 22(9):590–595.
- Ahimastos AA, Natoli AK, Lawler A, Blombery PA, Kingwell BA. Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture. Hypertension 2005; 45(6):1194–1199.
- Montecucco F, Pende A, Mach F. The rennin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies. Mediators Infl Amm 2009; 2009(4):752406.
- Ferreira AJ, Bader M, Santos RA. Therapeutic targeting of the angiotensin-converting enzyme 2/angiotensin-(1–7)/Mas cascade in the renin-angiotensin system: a patent review. Expert Opin Ther Pat 2012; 22(5):567–574.
- Ferreira AJ, Santos RA, Raizada MK. Angiotensin-(1–7)/angiotensin-converting enzyme 2/mas receptor axis and related mechanisms. Int J Hypertens. 2012; 2012:690785.
- Hu XS, Xie XD, Wang XX, . Effects of angiotensin converting enzyme inhibitor on the expression of angiotensin converting enzyme 2 in atrium of patients with atrial fibrillation. Zhonghua Xin Xue Guan Bing Za Zhi 2007; 35(7): 625–628.
- Do TH, Chen Y, Nguyen VT, Phisitkul S. Vaccines in the management of hypertension. Expert Opin Biol Ther 2010; 10(7): 1077–1087.
- Brown MJ. Success and failure of vaccines against renin-angiotensin system components. Nat Rev Cardiol 2009; 6(10): 639–647.
- Azegami T, Sasamura H, Hayashi K, Itoh H. Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy. Hypertens Res 2012; 35(5): 492–499.